Medgenics Announces the Appointment of Scott Applebaum as Chief Legal Officer

WAYNE, Pa. and MISGAV, Israel, Sept. 10, 2014 (GLOBE NEWSWIRE) — Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using ex vivo gene therapy and their own tissue for the treatment of rare and orphan diseases, today announced the appointment of Scott Applebaum as Chief Legal Officer.

This entry was posted in Recent Development News: Q3 – 2014. Bookmark the permalink.